After prescribing medications, what should be monitored?

After prescribing medications, what should be monitored?

• A. Monitor beneficial outcomes only
• B. Monitor adverse effects only
• C. Ignore patient-reported outcomes
• D. Monitor both beneficial and adverse outcomes

Answer: (D)

After prescribing medications, you should follow the patient to see both how well the therapy works and whether it causes problems. Beneficial outcomes include symptom relief and objective improvements (for example, lower blood pressure, better glucose control, reduced pain, or signs of infection clearing). Adverse effects encompass any side effects, lab abnormalities, or organ toxicity that the medicine might cause, which could lead to intolerance or harm if not addressed. Because patients’ experiences and reported symptoms matter for adherence and overall well-being, it’s important to collect both types of information over time. Monitoring only one side risks missing important issues or unnecessary continuation of ineffective or unsafe therapy, so evaluating the balance of benefits and harms guides dose adjustments, discontinuation, or switching therapies as needed. In practice, this means tracking clinical responses, safety signals from exams or labs, and patient-reported outcomes to ensure net benefit.

After prescribing medications, you should follow the patient to see both how well the therapy works and whether it causes problems. Beneficial outcomes include symptom relief and objective improvements (for example, lower blood pressure, better glucose control, reduced pain, or signs of infection clearing). Adverse effects encompass any side effects, lab abnormalities, or organ toxicity that the medicine might cause, which could lead to intolerance or harm if not addressed. Because patients’ experiences and reported symptoms matter for adherence and overall well-being, it’s important to collect both types of information over time. Monitoring only one side risks missing important issues or unnecessary continuation of ineffective or unsafe therapy, so evaluating the balance of benefits and harms guides dose adjustments, discontinuation, or switching therapies as needed. In practice, this means tracking clinical responses, safety signals from exams or labs, and patient-reported outcomes to ensure net benefit.